Home / Cancer and immune system / Fulvestrant
ATC L02BA03 · Endocrine Therapy
Fulvestrant shortage
As of 31 Oct 2026, Fulvestrant has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 6 products.
Countries3/5
Products6packs or presentations
Short since13 May 202518 months ago
Earliest return2 Nov 2026company estimate
No return date3products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | FULVESTRANT ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Aug 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | FULVESTRANT ACCORD | ACCORD HEALTHCARE, S.L.U. | 31 May 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | FULVESTRANT DR. REDDY'S | DR. REDDY'S S.R.L. | 2 Oct 2026 | not given | Increased demand Elevata richiesta: forniture discontinue |
| ES | FULVESTRANT EUGIA 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 1 jeringa + 1 aguja | Eugia Pharma (Malta) Limited | 13 May 2025 | 29 Nov 2026 | Not stated |
| ES | ONNIMIA 250 MG SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA EFG 2 jeringas precargadas de 5 ml + 2 agujas | Adamed Laboratorios S.L.U. | 18 Jun 2026 | 19 Nov 2026 | Not stated |
| BE | Fulvestrant Accord 250 mg inj. sol. i.m. pre-filled syr. 2 x 5 ml | Accord Healthcare | 16 Jun 2026 | 2 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.